CompoAtlas

OK Look

Food supplement declared in France, declaration No 2020-7-588, decision dated 10 July 2020

OK Look is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
Mulberry Corp. Limited
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1
Directions for use
1 gélule par jour, à consommer après le repas
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Eye / Vision

Declaration 310261, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Vaccinium myrtillus L.BaieExtrait sec aqueux70 mg

Other active ingredients

NamePer day
Zéaxanthinenot declared
Lutéinenot declared

Other ingredients

maltodextrine, gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

La dose journalière recommandée ne doit pas être dépassée. Garder hors de portée des enfants ! Ne pas utiliser chez les femmes enceintes ou allaitantes. Ne pas utiliser en cas d'allergie à l'un des ingrédients. Comme pour tout complément alimentaire, consultez un professionnel de santé si vous avez un problème de santé.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line